|
Market Closed -
Nasdaq
21:00:00 18/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 56.87 USD | +0.71% |
|
+5.53% | +90.77% |
| 08-03 | TG Therapeutics, Inc. Raises Earnings Guidance for the Full Year 2026 | CI |
| 08-03 | TG Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 8.07B 7.02B 6.63B 6.02B 11.28B 773B 11.32B 79.29B 30.65B 393B 30.3B 29.63B 1,265B | P/E 2026 * |
60.1x | P/E 2027 * | 19.9x |
|---|---|---|---|---|---|
| Enterprise Value | 8.24B 7.17B 6.77B 6.15B 11.52B 790B 11.56B 80.95B 31.29B 402B 30.94B 30.25B 1,292B | EV / Sales 2026 * |
8.58x | EV / Sales 2027 * | 5.86x |
| Free-Float |
88.56% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TGTX | Delayed | |
CBOE
| TGTX | Real-time | |
|
Borsa Italiana
| 1TGTX | End-of-day quote | |
|
London S.E.
| 0VGI | Delayed | |
|
Deutsche Boerse AG
| NKB2 | Delayed | |
|
Tradegate
| NKB2 | Real-time | |
|
Börse Stuttgart
| NKB2 | Delayed | |
|
Boerse Muenchen
| NKB2 | Real-time | |
|
Berne S.E.
| NKB2 | End-of-day quote |
Last Transcript: TG Therapeutics, Inc.
| 1 day | +0.71% | ||
| 1 week | +5.53% | ||
| Current month | +4.73% | ||
| 1 month | +10.02% | ||
| 3 months | +6.86% | ||
| 6 months | +87.32% | ||
| Current year | +90.77% |
| 1 week | 52.5 |  | 57.87 |
| 1 month | 49.97 | | 58.47 |
| Current year | 26.76 | | 59.3 |
| 1 year | 26.76 | | 59.3 |
| 3 years | 6.46 | | 59.3 |
| 5 years | 3.48 | | 59.3 |
| 10 years | 3.32 | | 59.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Weiss
CEO | Chief Executive Officer | 60 | 28/12/2011 |
Sean Power
DFI | Director of Finance/CFO | 44 | 28/12/2011 |
Jenna A. Bosco
IRC | Investor Relations Contact | - | 30/11/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Weiss
CHM | Chairman | 60 | 28/12/2011 |
Laurence Charney
BRD | Director/Board Member | 79 | 29/02/2012 |
Yann Echelard
BRD | Director/Board Member | 62 | 08/11/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/09/26 | Sell | Director | -5,000 | 0.0033% | ||
| 07/08/26 | Don | Director | -950 | 0.0006% | ||
| 28/01/26 | Don | Director | 43,197 | 0.0272% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.71% | +5.53% | +75.69% | +493.01% | 8.07B | |
| +0.04% | +3.34% | +53.32% | +100.52% | 1,028B | |
| -0.09% | +1.66% | +53.24% | +66.45% | 651B | |
| -0.02% | +2.66% | +18.65% | +71.97% | 466B | |
| -1.22% | +3.66% | +34.59% | +38.81% | 346B | |
| -0.79% | +2.73% | +17.73% | +25.11% | 266B | |
| +0.58% | +6.76% | +10.58% | +17.75% | 259B | |
| +1.55% | +2.20% | +35.12% | +45.91% | 208B | |
| +0.79% | +1.84% | -27.55% | -56.48% | 191B | |
| -0.52% | +4.45% | +31.57% | +98.11% | 186B | |
| Average | +0.10% | +3.48% | +30.29% | +90.12% | 360.98B | |
| Weighted average by Cap. | -0.03% | +3.10% | +34.94% | +62.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 960M 836M 789M 717M 1.34B 92.04B 1.35B 9.44B 3.65B 46.82B 3.61B 3.53B 151B | 1.32B 1.15B 1.08B 984M 1.84B 126B 1.85B 12.95B 5.01B 64.28B 4.95B 4.84B 207B |
| Net income | 157M 137M 129M 118M 220M 15.09B 221M 1.55B 598M 7.68B 591M 578M 24.69B | 450M 392M 370M 336M 629M 43.15B 632M 4.42B 1.71B 21.95B 1.69B 1.65B 70.61B |
| Net Debt | 169M 147M 139M 126M 236M 16.2B 237M 1.66B 642M 8.24B 635M 621M 26.51B | -348M -303M -286M -260M -487M -33.36B -489M -3.42B -1.32B -16.97B -1.31B -1.28B -54.59B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | US$56.87 | +0.71% | 5,168,992 |
| 17/09/26 | US$56.47 | +1.11% | 1,467,994 |
| 16/09/26 | US$55.85 | +5.30% | 2,350,124 |
| 15/09/26 | US$53.04 | -1.78% | 1,758,959 |
| 14/09/26 | US$54.00 | +0.20% | 1,362,263 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TGTX Stock
Select your edition
All financial news and data tailored to specific country editions
